Literature DB >> 8959496

Endovascular management of unusual aneurysms of the axillary and subclavian arteries.

T M Sullivan1, J M Bacharach, J Perl, B Gray.   

Abstract

PURPOSE: Aneurysms of the upper extremity arteries are uncommon and may be difficult to manage with standard surgical techniques. We report the exclusion of three axillary-subclavian aneurysms with covered stents. METHODS AND
RESULTS: Palmaz stents were covered with either polytetrafluoroethylene (2 cases) or brachial vein and deployed to exclude pseudoaneurysms in 1 axillary (ruptured) and 2 left subclavian arteries. Two of the patients had advanced cancer and died within 52 days and 3 months of treatment, but their aneurysms were occluded at the time of their death. The repair in the third patient is patent at 9 months.
CONCLUSIONS: Endovascular exclusion of axillary and subclavian aneurysms with covered stents may offer a useful alternative to operative repair, particularly in patients with significant comorbidities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959496     DOI: 10.1177/152660289600300406

Source DB:  PubMed          Journal:  J Endovasc Surg        ISSN: 1074-6218


  3 in total

Review 1.  Role of Interventional Radiology in the Management of Non-aortic Thoracic Trauma.

Authors:  Mikhail C S S Higgins; Jessica Shi; Mohammad Bader; Paul A Kohanteb; Tejal S Brahmbhatt
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

2.  Endovascular treatment of iatrogenic axillary artery pseudoaneurysm under echographic control: a case report.

Authors:  Daniela Mazzaccaro; Giovanni Malacrida; Maria T Occhiuto; Silvia Stegher; Domenico G Tealdi; Giovanni Nano
Journal:  J Cardiothorac Surg       Date:  2011-05-27       Impact factor: 1.637

3.  Case report of emergency repair of injury to the great vessels of the clavicular region by coated endovascular stent implantation.

Authors:  Jian Wang; Jie Lao; Yangbo Liu; Gaobao Zhuo; Huaibao Zhang; Lei Chen
Journal:  Exp Ther Med       Date:  2013-05-02       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.